Cyano Biotech

Berlin, Germany Founded: 2004 • Age: 22 yrs Acquired By Simris Alg
German biotech developing therapeutic drugs and other applications from cyanobacteria.
Request Access

About Cyano Biotech

Cyano Biotech is a company based in Berlin (Germany) founded in 2004 was acquired by Simris Alg in August 2022.. Cyano Biotech operates in a competitive market with competitors including Jazz Pharmaceuticals, GSK, C4 Therapeutics, Erasca and MiRagen, among others.

  • Headquarter Berlin, Germany
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cyano Biotech Gmbh
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $205.97 K (USD), Grant

    Sep 01, 2020

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Simris Alg

    (Aug 25, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Cyano Biotech

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $205,968
  • First Round

    (09 Jan 2020)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2020 Amount Grant - Cyano Biotech Valuation

investors

Jan, 2020 Amount Grant - Cyano Biotech Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cyano Biotech

Cyano Biotech has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Simris Alg. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Algae are cultivated, harvested, and processed into oils and products.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cyano Biotech

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Cyano Biotech

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cyano Biotech Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cyano Biotech

Cyano Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, GSK, C4 Therapeutics, Erasca and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
domain founded_year HQ Location
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
domain founded_year HQ Location
Small molecule therapeutics for cancer treatment are developed.
domain founded_year HQ Location
MicroRNA-based therapeutics are developed for treating multiple diseases.
domain founded_year HQ Location
Cancer therapies are developed using selective pathway inhibitors.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cyano Biotech

Frequently Asked Questions about Cyano Biotech

When was Cyano Biotech founded?

Cyano Biotech was founded in 2004 and raised its 1st funding round 16 years after it was founded.

Where is Cyano Biotech located?

Cyano Biotech is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.

What does Cyano Biotech do?

Cyano Biotech was founded in 2004 and is based in Berlin, Germany. Operations in the biotech sector focus on screening cyanobacteria to identify and characterize natural products. Two product lines have been developed: microcystins for potential antitumor use and microginins as ACE inhibitors. Services provided include strains cultivation, biomass growth, extraction, fractionation, and compound purification for clients.

Who are the top competitors of Cyano Biotech?

Cyano Biotech's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.

Who are Cyano Biotech's investors?

Cyano Biotech has 2 investors. Key investors include European Union, and Simris Alg.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available